Trending News

How Are Family Offices Building Smarter Wealth? Structural Alpha (11 Examples)

DOJ Rule Restricting Sensitive Data Transfers Takes Effect

The Trump Administration’s Diversity, Equity, and Inclusion (DEI) Executive Orders: A Brief Primer

Trump Administration Announces "Reciprocal" Tariffs

What Every Multinational Company Should Know About … The Global and Reciprocal Tariffs Announcement

Blockading the Ports: U.S. Imposes 10% Global Tariff; Higher Reciprocal Tariff Rates by Country

Fifth Circuit Court of Appeals Negates Ruling on Federal Contractor Minimum Wage

New Executive Order Rescinds the $17.75 Per Hour Federal Contractor Minimum Wage

Medicare Telehealth Gets Another Temporary Lifeline – Will Congress Make it Permanent?

BREAKING: District Court Restores Status Quo Ante At NLRB

GlobeNewswire Biotech

Website

www.globenewswire.com

Featured Biotech Press Releases From GlobeNewswire

BioXcel Therapeutics Regains Compliance with Nasdaq Minimum Bid Price Rule
Posted On Friday, February 28, 2025
Linvoseltamab Recommended for EU Approval by the CHMP to Treat Relapsed/Refractory Multiple Myeloma
Posted On Friday, February 28, 2025
ADMA Biologics to Participate in the Raymond James Institutional Investor Conference
Posted On Friday, February 28, 2025
Akero Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update
Posted On Friday, February 28, 2025
Achilles Therapeutics Announces Voluntary Nasdaq Delisting and SEC Deregistration
Posted On Friday, February 28, 2025
ANI Pharmaceuticals Reports Record Fourth Quarter and Full-Year 2024 Financial Results and Raises 2025 Guidance
Posted On Friday, February 28, 2025
Recursion Provides Business Updates and Reports Fourth Quarter and Fiscal Year 2024 Financial Results
Posted On Friday, February 28, 2025
Nxera Pharma Enters Agreement with Holling to Commercialize Daridorexant in Taiwan
Posted On Friday, February 28, 2025
Nxera Pharma Assigns Japan and APAC (ex-China) Rights to Cenerimod for Autoimmune Diseases to Viatris
Posted On Thursday, February 27, 2025
Skye Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Posted On Thursday, February 27, 2025
Alumis Presents Additional Phase 1 Data at ACTRIMS Forum 2025 Supporting Potential of A-005 as First-in-Class CNS Penetrant TYK2 Inhibitor for Treatment of Neuroinflammatory and Neurodegenerative Diseases
Posted On Thursday, February 27, 2025
Anaptys Announces Participation in March Investor Conferences
Posted On Thursday, February 27, 2025
Myriad Genetics and Gabbi to Work Together to Increase Access to Hereditary Cancer Risk Assessment Tools
Posted On Thursday, February 27, 2025
Anaptys Announces Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update
Posted On Thursday, February 27, 2025
Codexis Reports Fourth Quarter and Fiscal Year 2024 Financial Results
Posted On Thursday, February 27, 2025
Cardiff Oncology Reports Fourth Quarter and Full Year 2024 Results and Provides Business Update
Posted On Thursday, February 27, 2025
Cytek Biosciences Reports Fourth Quarter and Full Year 2024 Financial Results and Provides 2025 Outlook
Posted On Thursday, February 27, 2025
Crinetics Pharmaceuticals Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update
Posted On Thursday, February 27, 2025
Humacyte to Present at the TD Cowen 45th Annual Health Care Conference
Posted On Thursday, February 27, 2025
Lisata Therapeutics Reports Full Year 2024 Financial Results and Provides Business Update
Posted On Thursday, February 27, 2025
Mustang Bio Announces Sale of Fixed Assets and Exit of Facility
Posted On Thursday, February 27, 2025
Pacira BioSciences Reports Fourth Quarter and Full-Year 2024 Financial Results
Posted On Thursday, February 27, 2025
89bio Reports Fourth Quarter and Full Year 2024 Financial Results and Corporate Updates
Posted On Thursday, February 27, 2025
Organogenesis Holdings Inc. Reports Fourth Quarter 2024 Financial Results
Posted On Thursday, February 27, 2025
TELA Bio to Announce Fourth Quarter and Full Year 2024 Financial Results
Posted On Thursday, February 27, 2025

Print